The Association for the Cannabinoid Industry (ACI) is a membership organisation for businesses committed to nurturing a safe, legal and flourishing commercial cannabis extract market in the UK and Europe.
Our vision is to create an innovative and ethical sector with the highest standards of product quality, consumer satisfaction and regulatory compliance. All our members sign up to our quality charter.
We deliver vital stewardship for this emerging sector through constructive engagement with key stakeholders and thought leaders. To find out what we’ve achieved see our list of milestones.
Our team of scientific, regulatory and industry leaders provide expert support and guidance to our members.
ACI in the Media
Last February, the Food Standards Agency (FSA) announced that all CBD businesses operating in England and Wales must have a novel foods application “validated” by March 31, 2021, or risk having their CBD oils, drinks, and treats “taken off the shelves.” Now, with just over two weeks left until the deadline, the FSA has clarified that all applications just have to be “submitted” by March 31, 2021.
Coverage from the US publication Hemp Grower on the requirement for novel foods applications to sell CBD products in the UK.
[Cannavist] The Food Standards Agency (FSA) has updated its criteria for CBD products to remain on sale after April 1
Previously, only products that were on sale on February 13, 2020 and linked to an application that had been validated by the March 31, 2021 deadline could continue to be sold.
The criteria for CBD products which can remain on sale from 1 April 2021 has been updated by the Food Standards Agency (FSA).
The FSA has backtracked on its initial expectation for companies to make their novel foods applications at least five weeks in advance of the deadline and confirmed that it will accept applications up until March 31st, after receiving a large number of last minute dossiers.
Many UK CBD brands have been misled on how to prepare for the looming novel foods deadline meaning there is less than one month for some to pull together potentially impossible amounts of data, an industry expert has warned.
Writing for BusinessCann, Dr Paul Duffy, Toxicology Associate, at the ACI, elaborates on our Novel Food applications and the significance of these development for the the CBD industry
[Pharmacy Business Magazine] Industry body submits CBD novel food application for validation by Food Standards Agency
The Association for the Cannabinoid Industry (ACI) has submitted its novel food application to the FSA on behalf of CBD manufacturers. This marks a pivotal milestone for the ACI as it met the compliance deadline set by the UK’s Food Standards Agency (FSA), the association said in an update on Tuesday (Feb 16).
Following the submission of its novel food application, New Food gets exclusive insight from three experts integral to the study…